| Literature DB >> 20298523 |
Beining Chen1, Christoph Mueller, Peter Willett.
Abstract
BACKGROUND: Bayesian inference networks enable the computation of the probability that an event will occur. They have been used previously to rank textual documents in order of decreasing relevance to a user-defined query. Here, we modify the approach to enable a Bayesian inference network to be used for chemical similarity searching, where a database is ranked in order of decreasing probability of bioactivity.Entities:
Year: 2009 PMID: 20298523 PMCID: PMC3225873 DOI: 10.1186/1758-2946-1-5
Source DB: PubMed Journal: J Cheminform ISSN: 1758-2946 Impact factor: 5.514
Figure 1Use of a Bayesian inference network for information retrieval. In the chemoinformatics context, the Document network describes the structures of the database molecules, and the Query network describes the reference structure that is to be searched against this database.
Overlap of actives (mean and standard deviation) in the top-1% search outputs from SUM-OKA and TAN searches: percentage of active molecules retrieved by both SUM-OKA and TAN ("Overlap") or only by one of these two search methods.
| Percentage of actives | ||||||
|---|---|---|---|---|---|---|
| Dataset | Overlap | SUM-OKA | TAN | |||
| MDDR | 14.81 | 12.67 | 6.58 | 4.28 | 4.40 | 2.23 |
| MDDR-HOM | 69.21 | 18.48 | 13.39 | 8.84 | 3.58 | 3.75 |
| MDDR-HET | 7.05 | 6.36 | 2.38 | 1.86 | 4.71 | 3.75 |
| WOMBAT | 22.37 | 16.01 | 8.43 | 5.38 | 3.84 | 2.01 |
Overlap of actives (mean and standard deviation) in the top-1% search outputs from SUM-OKA and TAN searches: number of active molecules retrieved by both SUM-OKA and TAN ("Overlap") or only by one of these two search methods.
| Number of actives | ||||||
|---|---|---|---|---|---|---|
| Dataset | Overlap | SUM-OKA | TAN | |||
| MDDR | 131.58 | 154.10 | 56.41 | 47.71 | 35.89 | 27.40 |
| MDDR-HOM | 234.54 | 262.74 | 63.53 | 91.37 | 21.39 | 42.69 |
| MDDR-HET | 44.17 | 35.17 | 14.89 | 8.52 | 32.56 | 29.79 |
| WOMBAT | 122.80 | 71.39 | 56.37 | 44.62 | 26.84 | 21.05 |
MDDR activity classes used in the virtual screening experiments.
| Activity class | Active molecules | Pairwise similarity | |
|---|---|---|---|
| Renin inhibitors | 1130 | 0.573 | 0.11 |
| HIV protease inhibitors | 750 | 0.446 | 0.12 |
| Thrombin inhibitors | 803 | 0.419 | 0.13 |
| Angiotensin II AT1 antagonists | 943 | 0.403 | 0.10 |
| Substance P antagonists | 1246 | 0.399 | 0.11 |
| 5HT3 antagonists | 752 | 0.351 | 0.12 |
| 5HT reuptake inhibitors | 359 | 0.345 | 0.12 |
| D2 antagonists | 395 | 0.345 | 0.10 |
| 5HT1A agonists | 827 | 0.343 | 0.10 |
| Protein kinase C inhibitors | 453 | 0.323 | 0.14 |
| Cyclooxygenase inhibitors | 636 | 0.268 | 0.09 |
The three columns in each table give the number of actives in the class and the mean and the standard deviation of the inter-molecular similarities for all the molecules in the chosen class.
MDDR-HOM activity classes used in the virtual screening experiments.
| Activity class | Active molecules | Pairwise similarity | |
|---|---|---|---|
| Muscarinic (M1) agonists | 848 | 0.206 | 0.098 |
| NMDA receptor antagonists | 1311 | 0.199 | 0.090 |
| Nitric oxide synthase inhibitors | 377 | 0.189 | 0.086 |
| Dopamine beta-hydroxylase inhibitors | 95 | 0.229 | 0.076 |
| Aldose reductase inhibitors | 882 | 0.232 | 0.096 |
| Reverse transcriptase inhibitors | 519 | 0.218 | 0.095 |
| Aromatase inhibitors | 513 | 0.229 | 0.117 |
| Cyclooxygenase inhibitors | 636 | 0.220 | 0.107 |
| Phospholipase A2 inhibitors | 704 | 0.224 | 0.111 |
| Lipoxygenase inhibitors | 2555 | 0.224 | 0.110 |
Details as for Table 3.
MDDR-HET activity classes used in the virtual screening experiments.
| Activity class | Active molecules | Pairwise similarity | |
|---|---|---|---|
| Adenosine (A1) agonists | 88 | 0.524 | 0.124 |
| Adenosine (A2) agonists | 71 | 0.536 | 0.137 |
| Renin inhibitors | 1130 | 0.459 | 0.119 |
| CCK agonists | 79 | 0.452 | 0.099 |
| Monocyclic beta-lactams | 76 | 0.549 | 0.084 |
| Cephalosporins | 1312 | 0.501 | 0.098 |
| Carbacephems | 73 | 0.487 | 0.099 |
| Carbapenems | 896 | 0.457 | 0.124 |
| Tribactams | 74 | 0.548 | 0.150 |
| Vitamin D analogues | 279 | 0.574 | 0.105 |
Details as for Table 3.
WOMBAT activity classes used in the virtual screening experiments.
| Activity class | Active molecules | Pairwise similarity | |
|---|---|---|---|
| Renin inhibitors | 474 | 0.592 | 0.109 |
| Protein kinase C inhibitors | 142 | 0.565 | 0.277 |
| Matrix metalloprotease inhibitors | 694 | 0.444 | 0.148 |
| Angiotensin II AT1 antagonists | 724 | 0.443 | 0.131 |
| HIV protease inhibitors | 1128 | 0.442 | 0.146 |
| Substance P antagonists | 558 | 0.427 | 0.127 |
| Thrombin inhibitors | 421 | 0.418 | 0.144 |
| 5HT1A antagonists | 592 | 0.399 | 0.134 |
| Factor Xa inhibitors | 842 | 0.394 | 0.124 |
| 5HT3 antagonists | 220 | 0.377 | 0.175 |
| Acetylcholine esterase inhibitors | 503 | 0.373 | 0.155 |
| D2 antagonists | 910 | 0.367 | 0.116 |
| Phosphodiesterase inhibitors | 596 | 0.359 | 0.136 |
| Cyclooxygenase inhibitors | 965 | 0.324 | 0.139 |
Details as for Table 3.